Live Breaking News & Updates on Tim Haines Abingworth

IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , Oliver Nussbaumer , Frazer Hall , Leila Adlam , Inga Deakin , Tim Haines Abingworth , Adam Laing , Tom Hayday , Tim Haines , Mario Cantero , Adaptate Biotherapeutics , Entrepreneur In Residence At Duke University , Professor Adrian Hayday At King College London , Head Of Communications , Non Executive Chair , Gammadelta Therapeutics , Molten Ventures , Lifex Ventures , Executive Partner , Executive Scientific Director , Cell Therapy Innovations , Chief Executive Officer , Chief Scientific Officer , Chief Operating Officer , Professor Adrian Hayday ,